| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal Cancer
|
Chuang, Jeremy
|
|
|
21 |
3 |
p. 252-258
|
artikel
|
| 2 |
Clinical Updates for Colon Cancer Care in 2022
|
Fabregas, Jesus C.
|
|
|
21 |
3 |
p. 198-203
|
artikel
|
| 3 |
Correlative Significance of Tumor Regression Grade and ypT Category in Patients Undergoing Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
|
Ryu, Hyo Seon
|
|
|
21 |
3 |
p. 212-219
|
artikel
|
| 4 |
Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer
|
Brooks, Gabriel A.
|
|
|
21 |
3 |
p. e189-e195
|
artikel
|
| 5 |
Cure Rates According to Dose-Intensity of Chemoradiation in T2N0 Squamous Cell Carcinoma of the Anal Canal
|
Lustosa, Iara K.F.
|
|
|
21 |
3 |
p. e226-e231
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
21 |
3 |
p. A1
|
artikel
|
| 7 |
Efficacy and Safety Comparison of Regorafenib and Fruquintinib in Metastatic Colorectal Cancer-An Observational Cohort Study in the Real World
|
Zhang, Qi
|
|
|
21 |
3 |
p. e152-e161
|
artikel
|
| 8 |
Encorafenib in Combination With Cetuximab After Systemic Therapy in Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: German Health Technology Assessment-Driven Analyses From the BEACON CRC Study
|
Stintzing, Sebastian
|
|
|
21 |
3 |
p. 244-251
|
artikel
|
| 9 |
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial
|
Arai, Hiroyuki
|
|
|
21 |
3 |
p. 259-266
|
artikel
|
| 10 |
“Global Multidisciplinary Team Meetings”: Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)
|
Segelov, Eva
|
|
|
21 |
3 |
p. 175-187
|
artikel
|
| 11 |
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
|
Sclafani, Francesco
|
|
|
21 |
3 |
p. 188-197
|
artikel
|
| 12 |
Impact of the COVID-19 Pandemic on Colorectal Cancer Care in the Netherlands: A Population-based Study
|
Meijer, Joyce
|
|
|
21 |
3 |
p. e171-e178
|
artikel
|
| 13 |
Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized Trial
|
Ominelli, Juliana
|
|
|
21 |
3 |
p. e196-e204
|
artikel
|
| 14 |
Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence
|
Khan, Zooha
|
|
|
21 |
3 |
p. 204-211
|
artikel
|
| 15 |
Laparoscopic Colectomy: A Risk Factor for Postoperative Peritoneal Metastasis
|
Nagata, Hiroshi
|
|
|
21 |
3 |
p. e205-e212
|
artikel
|
| 16 |
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer
|
Punt, Cornelis J.A.
|
|
|
21 |
3 |
p. 229-235
|
artikel
|
| 17 |
Post-induction Strategies in Metastatic Colorectal Cancer Patients Treated With First-Line Anti-EGFR-Based Treatment: A Systematic Review and Meta-Analysis
|
Parisi, Alessandro
|
|
|
21 |
3 |
p. e162-e170
|
artikel
|
| 18 |
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO
|
Dell'Aquila, Emanuela
|
|
|
21 |
3 |
p. 220-228
|
artikel
|
| 19 |
Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis
|
Meyer, Hans-Jonas
|
|
|
21 |
3 |
p. e213-e225
|
artikel
|
| 20 |
QUAD SHOT Radiotherapy and Doublet Immunotherapy in the Management of Anal Mucosal Melanoma: A Case Series of Efficacy and Toxicity of a Novel Treatment Approach and a Review of the Literature
|
Higgins, Martin J.
|
|
|
21 |
3 |
p. e179-e186
|
artikel
|
| 21 |
Rechallenge With BRAF and anti-EGFR Inhibitors in Patients With Metastatic Colorectal Cancer Harboring BRAFV600E Mutation Who Progressed on Cetuximab and Encorafenib With or Without Binimetinib: A Case Series
|
Ji, Jingran
|
|
|
21 |
3 |
p. 267-271
|
artikel
|
| 22 |
Restoring Immune Mediated Disease Control by Ipilimumab Re-exposition in a Heavily pretreated Patient With MSI-H mCRC
|
Jordan, Frank
|
|
|
21 |
3 |
p. e148-e151
|
artikel
|
| 23 |
Safety and Efficacy of Avelumab in Small Bowel Adenocarcinoma
|
Cardin, Dana B.
|
|
|
21 |
3 |
p. 236-243
|
artikel
|
| 24 |
Table of contents
|
|
|
|
21 |
3 |
p. A3-A6
|
artikel
|
| 25 |
Targeted Fibroblast Growth Factor Receptor (FGFR) Inhibition in Recurrent, Metastatic Anal Carcinoma: A Case Report
|
Miranda, Kayla W.
|
|
|
21 |
3 |
p. 272-275
|
artikel
|
| 26 |
Thinking Too Fast About Chemotherapy for Resectable Colorectal Cancer Liver Metastases?
|
Pereira, Allan A. Lima
|
|
|
21 |
3 |
p. e187-e188
|
artikel
|
Tijdschrift beschrijving